Peer-reviewedCC BY-NCChina CDC weekly
Safety of PCV13 with Different Carrier Proteins (CRM197, TT, and TT/DT) — Jiangsu Province, China, 2022–2024
- 1Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention (Jiangsu Provincial Academy of Preventive Medicine), Nanjing City, Jiangsu Province, China
Related
- Knowledge, Attitudes, and Practices Related to Polyendocrine Metabolic Ovarian Syndrome Among Women with PMOS in Jiangsu Province, China: A Cross-sectional Study
- Molecular epidemiology of influenza A (H5N6) viruses from human infections in Jiangsu Province, China
- Epidemiological patterns and surveillance-based forecasting of severe fever with thrombocytopenia syndrome in Jiangsu Province, China, 2015–2025
- Spatial and seasonal patterns of tick distribution and climate-driven shifts in Jiangsu Province, an SFTS-affected region of eastern China
- Plasma Carrier Proteins as Supramolecular Nanovectors for Cancer Therapy: The Trojan Horse Approach
BibTeX
@article{li2026safety,
title = {{Safety of PCV13 with Different Carrier Proteins (CRM197, TT, and TT/DT) — Jiangsu Province, China, 2022–2024}},
author = {Xun Li and Borong Xu and Zhiguo Wang and Hongxiong Guo and Yuanyuan Zhu and Ran Hu and Jing Yu},
journal = {China CDC weekly},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13673390},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Safety of PCV13 with Different Carrier Proteins (CRM197, TT, and TT/DT) — Jiangsu Province, China, 2022–2024
AU - Xun Li
AU - Borong Xu
AU - Zhiguo Wang
AU - Hongxiong Guo
AU - Yuanyuan Zhu
AU - Ran Hu
AU - Jing Yu
PY - 2026
DA - 2026/10/02
JO - China CDC weekly
UR - https://europepmc.org/article/PMC/PMC13673390
SN - 2096-7071
ER -